Medivir AB (publ)

OM:MVIR Stock Report

Market Cap: SEK 316.3m

Medivir Management

Management criteria checks 1/4

Medivir's CEO is Jens Lindberg, appointed in Jan 2022, has a tenure of 2.92 years. total yearly compensation is SEK7.82M, comprised of 32.8% salary and 67.2% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth SEK470.93K. The average tenure of the management team and the board of directors is 4.1 years and 1.3 years respectively.

Key information

Jens Lindberg

Chief executive officer

SEK 7.8m

Total compensation

CEO salary percentage32.8%
CEO tenure2.9yrs
CEO ownership0.1%
Management average tenure4.1yrs
Board average tenure1.3yrs

Recent management updates

Recent updates

Is Medivir (STO:MVIR) In A Good Position To Invest In Growth?

Nov 09
Is Medivir (STO:MVIR) In A Good Position To Invest In Growth?

Is Medivir (STO:MVIR) In A Good Position To Invest In Growth?

Jul 27
Is Medivir (STO:MVIR) In A Good Position To Invest In Growth?

Is Medivir (STO:MVIR B) In A Good Position To Deliver On Growth Plans?

Jan 09
Is Medivir (STO:MVIR B) In A Good Position To Deliver On Growth Plans?

CEO Compensation Analysis

How has Jens Lindberg's remuneration changed compared to Medivir's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 117m

Jun 30 2024n/an/a

-SEK 106m

Mar 31 2024n/an/a

-SEK 97m

Dec 31 2023SEK 8mSEK 3m

-SEK 89m

Sep 30 2023n/an/a

-SEK 87m

Jun 30 2023n/an/a

-SEK 78m

Mar 31 2023n/an/a

-SEK 75m

Dec 31 2022SEK 3mSEK 2m

-SEK 89m

Compensation vs Market: Jens's total compensation ($USD711.43K) is above average for companies of similar size in the Swedish market ($USD231.46K).

Compensation vs Earnings: Jens's compensation has increased whilst the company is unprofitable.

CEO

Jens Lindberg (53 yo)

2.9yrs

Tenure

SEK 7,824,000

Compensation

Mr. Jens Lindberg serves as Independent Chairman of the Board of BrainCool AB (publ) since December 3, 2024 and has been its Independent Director since June 26, 2024. He has many years of international exp...

Leadership Team

NamePositionTenureCompensationOwnership
Jens Lindberg
Chief Executive Officer2.9yrsSEK 7.82m0.15%
SEK 470.9k
Magnus Christensen
Chief Financial Officer5.3yrsSEK 2.66m0.081%
SEK 256.6k
Fredrik Öberg
Chief Scientific Officer5.3yrsno data0.11%
SEK 349.4k
Pia Baumann
Chief Medical Officer1.8yrsno data0.086%
SEK 270.7k
Karin Tunblad
Senior Principal Scientist & MIV-818 Project Leaderno datano datano data

4.1yrs

Average Tenure

55.5yo

Average Age

Experienced Management: MVIR's management team is considered experienced (4.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lennart Hansson
Independent Director6.6yrsSEK 260.00k0.036%
SEK 112.8k
Uli Hacksell
Chairman of the Board6.6yrsSEK 690.00k0.89%
SEK 2.8m
Yilmaz Mahshid
Director3.6yrsSEK 260.00k0.045%
SEK 141.0k
Jeong-Woo Heo
Member of Scientific Advisory Council1.3yrsno datano data
Bengt Westermark
Independent Director7.6yrsSEK 260.00k0.029%
SEK 90.2k
Jeffrey Evans
Member of Scientific Advisory Council1.3yrsno datano data
Richard Finn
Member of Scientific Advisory Council1.3yrsno datano data
Maria Reig
Member of Scientific Advisory Council1.3yrsno datano data
Arndt Vogel
Member of Scientific Advisory Council1.3yrsno datano data
Anna Torner
Directorless than a yearno datano data
Angelica Loskog
Directorless than a yearno datano data

1.3yrs

Average Tenure

74yo

Average Age

Experienced Board: MVIR's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 00:50
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medivir AB (publ) is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Morten LarsenABG Sundal Collier
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Revi MehrotraCredit Suisse